Suppr超能文献

双功超声、临床评分、血栓形成风险以及D - 二聚体检测,用于基层医疗和门诊病房中基于证据的深静脉血栓诊断与管理以及鉴别诊断。

Duplex ultrasound, clinical score, thrombotic risk, and D-dimer testing for evidence based diagnosis and management of deep vein thrombosis and alternative diagnoses in the primary care setting and outpatient ward.

作者信息

Michiels J J, Moosdorff W, Maasland H, Michiels J M, Lao M U, Neumann H A, Dulicek P, Stvrtinova V, Barth J, Palareti G

机构信息

Goodheart Institute, Blood coagulation & Vascular Medicine Center, Rotterdam, the Netherlands -

出版信息

Int Angiol. 2014 Feb;33(1):1-19.

Abstract

Deep vein thrombosis (DVT) has an annual incidence of 0.2% in the urban population. First episodes of calf vein thrombosis (CVT) and proximal DVT are frequently elicited by risk factors, including varicose veins, cancer, pregnancy/postpartum, oral contraceptives below the age of 50 years, immobility or surgery. Leg pain and tenderness in the calf and popliteal fossa on physical examination may result from other conditions than DVT labeled as alternative diagnosis (AD) Congenital venous thrombophilia is present in every third first DVT, increased FVIII in every fourth first DVT, and FV Leiden/FII mutation in 40% of women on oral anticonceptive pill before reaching the menopause. Routine thrombophilia testing for FV Leiden/prothrombin mutation and FVIII as main risk factor for venous thrombosis is recommended. Primary superficial venous thrombosis (SVT) and DVT patients with a autosomal dominant family history of DVT are candidates for thrombophilia testing for congenital AT, PC and PS deficiency. The requirement for a safe diagnostic strategy of CVT and DVT should be based on an objective post-test incidence of venous thromboembolism (VTE) of less than 0.1% with a negative predictive value for exclusion of DVT of 99.9% during 3 months follow-up. Modification of the Wells score by elimination of the "minus 2 points" for AD is mandatory and will improve the diagnostic accuracy of CVT/DVT suspicion in the primary care setting and outpatient ward. The sequential use of complete DUS, ELISA D-dimer testing and modified clinical Wells' score assessment is safe and effective for the exclusion and diagnosis of CVT, DVT and AD. About 10% to 20% of patients with DVT develop overt post-thrombotic syndrome (PTS) at one year post-DVT, and both PTS and DVT recurrences further increase to about 30% during long-term follow-up. Objective risk stratification of PTS complications using DUS for recanalization and reflux and D-dimer testing will become an integral part in routine clinical practice to assess the optimal duration of wearing medical elastic stockings and anticoagulation for the prevention DVT recurrence as the best option to reduce the incidence and costs of suffering from irreversible PTS.

摘要

深静脉血栓形成(DVT)在城市人口中的年发病率为0.2%。小腿静脉血栓形成(CVT)和近端DVT的首发通常由危险因素引发,包括静脉曲张、癌症、妊娠/产后、50岁以下口服避孕药、制动或手术。体格检查时小腿和腘窝处的腿痛和压痛可能由DVT以外的其他情况引起,这些情况被列为替代诊断(AD)。每三分之一的首发DVT患者存在先天性静脉血栓形成倾向,每四分之一的首发DVT患者FVIII升高,40%在绝经前服用口服避孕药的女性存在FV Leiden/FII突变。建议对FV Leiden/凝血酶原突变和FVIII作为静脉血栓形成的主要危险因素进行常规血栓形成倾向检测。原发性浅静脉血栓形成(SVT)以及有DVT常染色体显性家族史的DVT患者是进行先天性抗凝血酶(AT)、蛋白C(PC)和蛋白S(PS)缺乏症血栓形成倾向检测的对象。CVT和DVT安全诊断策略的要求应基于静脉血栓栓塞症(VTE)的客观检测后发病率低于0.1%,且在3个月随访期间排除DVT的阴性预测值为99.9%。必须通过消除AD的“减2分”来修改Wells评分,这将提高初级保健机构和门诊病房中CVT/DVT疑似病例的诊断准确性。序贯使用完整的超声检查(DUS)、ELISA D-二聚体检测和修改后的临床Wells评分评估对于CVT、DVT和AD的排除和诊断是安全有效的。约10%至20%的DVT患者在DVT发生后1年出现明显的血栓后综合征(PTS),在长期随访中,PTS和DVT复发率进一步增加至约30%。使用DUS评估再通和反流以及D-二聚体检测对PTS并发症进行客观风险分层将成为常规临床实践的一个组成部分,以评估穿戴医用弹力袜和抗凝预防DVT复发的最佳持续时间,这是降低不可逆PTS发病率和成本的最佳选择。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验